Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Transl Stroke Res. 2012 Jul;3(Supplement 1):166–173. doi: 10.1007/s12975-012-0172-y

Figure 4. Case D.

Figure 4

A. Select axial image MR angiography, baseline prior to injection

B. Baseline 3D T2*-GE MRI

C. Five days post-ferumoxytol injection T2*-GE MR. Residual intravascular signal loss is present in cortical vessels, although not in sagittal sinus.

D. Magnified view of baseline MRA

E. Magnified view of baseline 3D T2*-GE MRI

F. Magnified view of 5-day post-ferumoxytol injection 3D T2*-GE MRI. Arrows indicate areas of nidus with signal loss within discrete areas of the vascular walls, consistent with uptake of USPIO.